Comparison

Tacrolimus monohydrate European Partner

Item no. TMO-T20879-500mg
Manufacturer TargetMol
CASRN 109581-93-3
Amount 500 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 500 mg 50 mg 5 mg
Category
Type Inhibitors
Specific against other
Smiles O=C([C@@](CCCC1)([H])N1C(C([C@@]2(O)[C@H](C)C[C@H](OC)[C@@](O2)([H])[C@@H](OC)C[C@@H](C)C/C(C)=C/[C@H]3CC=C)=O)=O)O[C@H](/C(C)=C/[C@H]4C[C@@H](OC)[C@H](O)CC4)[C@H](C)[C@@H](O)CC3=O.O
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias FK 506,FK-506,FR 900506,Prograf,FR900506,Tacrolimus hydrate,LCP-Tacro
Shipping Condition Cool pack
Available
Manufacturer - Targets
Phosphatase|||Autophagy|||Antibacterial|||Antibiotic
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
822.05
Description
Tacrolimus monohydrate (LCP-Tacro) is a macrolide from the culture broth of a strain of Streptomyces tsukubaensis, binds to FK506 binding protein (FKBP) to form a complex. Tacrolimus inhibits calcineurin phosphatase, which inhibits T-lymphocyte signal transduction and IL-2 transcription. Immunosuppressive properties. It prevents the activation of T-lymphocytes in response to antigenic or mitogenic stimulation in vitro and has strong immunosuppressive activity in vivo.
Pathways
Microbiology/Virology|||Autophagy|||Metabolism

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close